1. Market Research
  2. > Healthcare Market Trends
  3. > United Arab Emirates Pharmaceuticals and Healthcare Report Q4 2016

United Arab Emirates Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 93 pages

Includes 3 FREE quarterly updates

BMI View:

The UAE will remain one of the most attractive pharmaceutical and healthcare markets in the Middle East and Africa Region. A rising chronic disease burden will drive demand for high-value medicines, particularly cancer drugs. The market is dominated by patented medicines, mainly imported from Western suppliers due to their perceived superiority. However, this current model is unsustainable over the long term and as such, the supply of generic cancer medicines in the UAE will increasingly be satisfied by the domestic industry, limiting the country's escalating healthcare costs.

Headline Expenditure Projections


- Pharmaceuticals: AED10.77bn (USD2.93bn) in 2015 to AED11.62bn (USD3.17bn) in 2016; +7.9% in local currency terms and +8.0% US dollar terms. Forecast in line with last quarter.

- Healthcare: AED56.32bn (USD15.33bn) in 2015 to AED59.18bn (USD16.13bn) in 2016; +5.1% in local currency terms and +5.2% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

United Arab Emirates Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United Arab Emirates 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Arab Emirates 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2012-2020) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2012-2020) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2012-2020) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Arab Emirates 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (United Arab Emirates 2014-2020) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (United Arab Emirates 2014-2020) 33
Industry Risk/Reward Index 34
Middle East and Africa Risk/Reward Index - Q4 2016 34
United Arab Emirates Risk/Reward Index 42
Rewards 42
Risks 42
Regulatory Review 44
Intellectual Property Issues 46
Pricing Regime 49
Market Overview 52
Healthcare Sector 53
Table: Healthcare Resources (United Arab Emirates 2010-2015) 57
Table: Healthcare Personnel (United Arab Emirates 2010-2015) 57
Table: Healthcare Activity (United Arab Emirates 2010-2015) 58
Research and Development 63
Clinical Trials 64
Epidemiology 65
Table: UAE Healthcare Demand Split By Therapeutic Area 67
Competitive Landscape 68
Research-Based Industry 68
Table: Abu Dhabi's Top Five Best Selling Drugs In Value Terms By Therapeutic Area 69
Table: Multinational Market Activity 71
Generic Drugmakers 72
Pharmaceutical Distribution and Retail Sector 73
Company Profile 75
Gulf Pharmaceutical Industries (Julphar) 75
Neopharma 79
Demographic Forecast 82
Demographic Outlook 82
Table: Population Headline Indicators (United Arab Emirates 1990-2025) 83
Table: Key Population Ratios (United Arab Emirates 1990-2025) 83
Table: Urban/Rural Population and Life Expectancy (United Arab Emirates 1990-2025) 84
Table: Population By Age Group (United Arab Emirates 1990-2025) 84
Table: Population By Age Group % (United Arab Emirates 1990-2025) 85
Glossary 87
Methodology 89
Pharmaceutical Expenditure Forecast Model 89
Healthcare Expenditure Forecast Model 89
Notes On Methodology 90
Risk/Reward Index Methodology 91
Index Overview 92
Table: Pharmaceutical Risk/Reward Index Indicators 92
Indicator Weightings 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


Download Unlimited Documents from Trusted Public Sources

Public Health Industry in the UK

  • December 2016
    156 pages
  • Public Health  

    Neurological Di...  

    Hospital  

  • United Kingdom  

View report >

Public Health Markets in the UK

  • December 2016
    45 pages
  • Public Health  

    Obesity  

    Food  

  • United Kingdom  

    Europe  

View report >

Breast Cancer Statistics in Africa

  • December 2016
    14 pages
  • Breast Cancer  

  • Africa  

View report >

Related Market Segments :

Healthcare
Pharmaceutical

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.